{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T01:15:12Z","timestamp":1782954912162,"version":"3.54.5"},"reference-count":87,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","maturitas.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Maturitas"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.maturitas.2022.06.001","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T16:52:59Z","timestamp":1654793579000},"page":"46-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Ketogenic therapy for Parkinson's disease: A systematic review and synthesis without meta-analysis of animal and human trials"],"prefix":"10.1016","volume":"163","author":[{"given":"Maria G.","family":"Grammatikopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Tousinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrysanthi","family":"Balodimou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios A.","family":"Anastasilakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Gkiouras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Efthimios","family":"Dardiotis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios E.","family":"Evangeliou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios P.","family":"Bogdanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios G.","family":"Goulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.maturitas.2022.06.001_bb0005","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/978-94-007-5416-4_16","article-title":"Parkinson's disease","volume":"65","author":"Mhyre","year":"2012","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0010","first-page":"406","article-title":"Parkinson disease in the elderly adult","volume":"110","author":"Willis","year":"2013","journal-title":"Mo. Med."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0015","first-page":"11","article-title":"Aggregation of \u03b1-synuclein in the pathogenesis of Parkinson's disease","volume":"250","author":"Baba","year":"2003","journal-title":"J. Neurol. Suppl."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0020","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of Parkinson disease: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.maturitas.2022.06.001_bb0025","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1093\/advances\/nmab060","article-title":"Dietary approaches to improve efficacy and control side effects of levodopa therapy in Parkinson's disease: a systematic review","volume":"12","author":"Keun","year":"2021","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0030","first-page":"1","article-title":"Parkinson's disease: the nutrition perspective","author":"Breasail","year":"2021","journal-title":"Proc. Nutr. Soc."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0035","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/ajcn\/77.1.128","article-title":"Effects of normal meals rich in carbohydrates or proteins on plasma tryptophan and tyrosine ratios","volume":"77","author":"Wurtman","year":"2003","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0040","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.nut.2009.05.021","article-title":"Dietary glycemic index is inversely associated with the risk of Parkinson\u2019s disease: a case-control study in Japan","volume":"26","author":"Murakami","year":"2010","journal-title":"Nutrition"},{"key":"10.1016\/j.maturitas.2022.06.001_bb0045","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1136\/jnnp.52.9.1063","article-title":"The effects of oral protein on the absorption of intraduodenal levodopa and motor performance","volume":"52","author":"Frankel","year":"1989","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.maturitas.2022.06.001_bb0050","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/archneur.1987.00520220009006","article-title":"Dietary influences on the antiparkinsonian response to levodopa","volume":"44","author":"Juncos","year":"1987","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0055","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1212\/WNL.41.8.1295","article-title":"A balanced carbohydrate: protein diet in the management of Parkinson's disease","volume":"41","author":"Berry","year":"1991","journal-title":"Neurology"},{"key":"10.1016\/j.maturitas.2022.06.001_bb0060","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1172\/JCI200318797","article-title":"D-beta-hydroxybutyrate rescues mitochondrial respiration and mitigates features of Parkinson disease","volume":"112","author":"Tieu","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0065","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1002\/mds.27390","article-title":"Low-fat versus ketogenic diet in Parkinson's disease: a pilot randomized controlled trial","volume":"33","author":"Phillips","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0070","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1001\/jama.1928.02690450007003","article-title":"The ketogenic diet","volume":"90","author":"Peterman","year":"1928","journal-title":"J. Am. Med. Assoc."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0075","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1007\/s13311-018-0666-8","article-title":"Ketogenic diets for adult neurological disorders","volume":"15","author":"McDonald","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.maturitas.2022.06.001_bb0080","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1093\/advances\/nmaa073","article-title":"To keto or not to keto? A systematic review of randomized controlled trials assessing the effects of ketogenic therapy on Alzheimer disease","volume":"11","author":"Grammatikopoulou","year":"2020","journal-title":"Adv. Nutr."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0085","doi-asserted-by":"crossref","DOI":"10.1007\/s13668-022-00405-4","article-title":"The efficacy and safety of ketogenic diets in drug-resistant epilepsy in children and adolescents: a systematic review of randomized controlled trials","author":"Desli","year":"2022","journal-title":"Curr. Nutr. Rep."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0090","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.maturitas.2022.06.001_bb0095","doi-asserted-by":"crossref","first-page":"I6890","DOI":"10.1136\/bmj.l6890","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.maturitas.2022.06.001_bb0100","doi-asserted-by":"crossref","first-page":"A12","DOI":"10.7326\/ACPJC-1995-123-3-A12","article-title":"The well-built clinical question: a key to evidence-based decisions - PubMed","volume":"123","author":"Richardson","year":"1995","journal-title":"ACP J. Club"},{"key":"10.1016\/j.maturitas.2022.06.001_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187271","article-title":"Facilitating healthcare decisions by assessing the certainty in the evidence from preclinical animal studies","volume":"13","author":"Hooijmans","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.maturitas.2022.06.001_bb0110","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst. Rev."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0115","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1002\/mds.22340","article-title":"Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results","volume":"23","author":"Goetz","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0120","series-title":"Encycl. Clin. Neuropsychol","first-page":"703","article-title":"Controlled oral word association test","author":"Patterson","year":"2011"},{"key":"10.1016\/j.maturitas.2022.06.001_bb0125","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.acn.2006.06.002","article-title":"The California Verbal Learning Test \u2013 second edition: test-retest reliability, practice effects, and reliable change indices for the standard and alternate forms","volume":"21","author":"Woods","year":"2006","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0130","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1093\/arclin\/17.6.567","article-title":"Verbal paired associates tests limits on validity and reliability","volume":"17","author":"Uttl","year":"2002","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0135","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"Br. Med. J."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0140","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE's risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med. Res. Methodol."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0145","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/jrsm.1060","article-title":"The effect direction plot: visual display of non-standardised effects across multiple outcome domains","volume":"4","author":"Thomson","year":"2013","journal-title":"Res. Synth. Methods"},{"key":"10.1016\/j.maturitas.2022.06.001_bb0150","series-title":"Cochrane Handb. Syst. Rev. Interv","first-page":"321","article-title":"Synthesizing and presenting findings using other methods","author":"McKenzie","year":"2019"},{"key":"10.1016\/j.maturitas.2022.06.001_bb0155","first-page":"41","article-title":"Nutritional ketosis for mild cognitive impairment in Parkinson's disease: a controlled pilot trial","volume":"1","author":"Krikorian","year":"2019","journal-title":"Clin. Park. Relat. Disord."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0160","doi-asserted-by":"crossref","DOI":"10.3389\/fnins.2020.584130","article-title":"A ketone ester drink enhances endurance exercise performance in Parkinson's disease","volume":"14","author":"Norwitz","year":"2020","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0165","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1007\/s13760-020-01486-0","article-title":"Effect of ketogenic diet versus regular diet on voice quality of patients with Parkinson's disease","volume":"121","author":"Koyuncu","year":"2021","journal-title":"Acta Neurol. Belg."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0170","doi-asserted-by":"crossref","first-page":"5259","DOI":"10.1007\/s11033-021-06532-5","article-title":"Caprylic acid ameliorates rotenone induced inflammation and oxidative stress in the gut-brain axis in zebrafish","volume":"48","author":"Cans\u0131z","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0175","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.brainres.2009.06.060","article-title":"Ketogenic diet protects dopaminergic neurons against 6-OHDA neurotoxicity via up-regulating glutathione in a rat model of Parkinson's disease","volume":"1286","author":"Cheng","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-021-02218-8","article-title":"High-fat diet-induced diabetes leads to vascular alterations, pericyte reduction, and perivascular depletion of microglia in a 6-OHDA toxin model of Parkinson disease","volume":"18","author":"Elabi","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.maturitas.2022.06.001_bb0185","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.pharep.2018.04.008","article-title":"Octanoic acid prevents reduction of striatal dopamine in the MPTP mouse model of Parkinson's disease","volume":"70","author":"Joniec-Maciejak","year":"2018","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0190","doi-asserted-by":"crossref","first-page":"7556","DOI":"10.3390\/ijms22147556","article-title":"Increased beta-hydroxybutyrate level is not sufficient for the neuroprotective effect of long-term ketogenic diet in an animal model of early Parkinson's disease. Exploration of brain and liver energy metabolism markers","volume":"22","author":"Kuter","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0195","first-page":"69","article-title":"The efficacy of the ketogenic diet on motor functions in Parkinson\u2019s disease: a rat model","volume":"15","author":"Shaafi","year":"2016","journal-title":"Iran. J. Neurol."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0200","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12031-010-9336-y","article-title":"Neuroprotective and anti-inflammatory activities of ketogenic diet on MPTP-induced neurotoxicity","volume":"42","author":"Yang","year":"2010","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0205","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0210","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","article-title":"Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases","volume":"55","author":"Hughes","year":"1992","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.maturitas.2022.06.001_bb0215","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/mds.24893","article-title":"Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society task force guidelines","volume":"27","author":"Litvan","year":"2012","journal-title":"Mov. Disord."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0220","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1002\/mds.26619","article-title":"Accuracy of patient and care partner identification of cognitive impairments in Parkinson's disease-mild cognitive impairment","volume":"31","author":"Copeland","year":"2016","journal-title":"Mov. Disord."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0225","series-title":"Encycl. Child Behav. Dev","first-page":"727","article-title":"Halstead-Reitan neuropsychological test battery","author":"Mazur-Mosiewicz","year":"2011"},{"key":"10.1016\/j.maturitas.2022.06.001_bb0230","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.jvoice.2004.03.003","article-title":"Psychometric evaluation of disease specific quality of life instruments in voice disorders","volume":"19","author":"Franic","year":"2005","journal-title":"J. Voice"},{"key":"10.1016\/j.maturitas.2022.06.001_bb0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jocn.2019.01.015","article-title":"Fishing for Parkinson's disease: a review of the literature","volume":"62","author":"\u00dcnal","year":"2019","journal-title":"J. Clin. Neurosci."},{"issue":"3","key":"10.1016\/j.maturitas.2022.06.001_bb0240","first-page":"1","article-title":"Parkinson disease","volume":"31","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0245","doi-asserted-by":"crossref","first-page":"868","DOI":"10.3389\/fnins.2019.00868","article-title":"The relevance of insulin action in the dopaminergic system","volume":"13","author":"Fiory","year":"2019","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0250","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009332","article-title":"Mitochondrial biology and Parkinson's disease","volume":"2","author":"Perier","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0255","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ebiom.2017.07.024","article-title":"ATP maintenance via two types of ATP regulators mitigates pathological phenotypes in mouse models of Parkinson's disease","volume":"22","author":"Nakano","year":"2017","journal-title":"EBioMedicine"},{"issue":"Pt 2","key":"10.1016\/j.maturitas.2022.06.001_bb0260","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1093\/brain\/123.2.340","article-title":"Cortical dysfunction in non-demented Parkinson's disease patients: a combined (31)P-MRS and (18)FDG-PET study","volume":"123","author":"Hu","year":"2000","journal-title":"Brain"},{"key":"10.1016\/j.maturitas.2022.06.001_bb0265","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2021.147434","article-title":"Is there a special relationship between complex I activity and nigral neuronal loss in Parkinson's disease?A critical reappraisal","volume":"1767","author":"Subrahmanian","year":"2021","journal-title":"Brain Res."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0270","doi-asserted-by":"crossref","first-page":"5440","DOI":"10.1073\/pnas.97.10.5440","article-title":"D-beta-hydroxybutyrate protects neurons in models of Alzheimer's and Parkinson's disease","volume":"97","author":"Kashiwaya","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0275","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1096\/fasebj.9.8.7768357","article-title":"Insulin, ketone bodies, and mitochondrial energy transduction","volume":"9","author":"Sato","year":"1995","journal-title":"FASEB J."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0280","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/bs.irn.2020.02.003","article-title":"Ketotherapeutics for neurodegenerative diseases","volume":"155","author":"Norwitz","year":"2020","journal-title":"Int. Rev. Neurobiol."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0285","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/iub.1627","article-title":"Ketone bodies mimic the life span extending properties of caloric restriction","volume":"69","author":"Veech","year":"2017","journal-title":"IUBMB Life"},{"key":"10.1016\/j.maturitas.2022.06.001_bb0290","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.diabres.2014.08.009","article-title":"\u03b2-Hydroxybutyrate: much more than a metabolite","volume":"106","author":"Newman","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0295","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.stem.2018.10.023","article-title":"Single-cell sequencing of iPSC-dopamine neurons reconstructs disease progression and identifies HDAC4 as a regulator of Parkinson cell phenotypes","volume":"24","author":"Lang","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.maturitas.2022.06.001_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2019.00184","article-title":"Multi-loop model of Alzheimer disease: an integrated perspective on the Wnt\/GSK3\u03b2, \u03b1-synuclein, and type 3 diabetes hypotheses","volume":"11","author":"Norwitz","year":"2019","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049191","article-title":"Caprylic triglyceride as a novel therapeutic approach to effectively improve the performance and attenuate the symptoms due to the motor neuron loss in ALS disease","volume":"7","author":"Zhao","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.maturitas.2022.06.001_bb0310","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1212\/01.WNL.0000152046.11390.45","article-title":"Treatment of Parkinson disease with diet-induced hyperketonemia: a feasibility study","volume":"64","author":"VanItallie","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.maturitas.2022.06.001_bb0315","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1007\/s13311-021-01067-w","article-title":"Nutritional ketosis in Parkinson's disease \u2014 a review of remaining questions and insights","volume":"18","author":"Choi","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.maturitas.2022.06.001_bb0320","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1002\/iub.1997","article-title":"The \u201cgreat\u201d controlling nucleotide coenzymes","volume":"71","author":"Veech","year":"2019","journal-title":"IUBMB Life"},{"key":"10.1016\/j.maturitas.2022.06.001_bb0325","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/S1474-4422(17)30408-8","article-title":"Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders","volume":"17","author":"Augustin","year":"2018","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0330","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3389\/fneur.2019.00585","article-title":"Ketone bodies in neurological diseases: focus on neuroprotection and underlying mechanisms","volume":"10","author":"Yang","year":"2019","journal-title":"Front. Neurol."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijms21228767","article-title":"Effects of ketone bodies on brain metabolism and function in neurodegenerative diseases","volume":"21","author":"Jensen","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0340","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.cmet.2016.12.022","article-title":"Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics","volume":"25","author":"Puchalska","year":"2017","journal-title":"Cell Metab."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0345","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neuint.2017.05.019","article-title":"Neuroketotherapeutics: a modern review of a century-old therapy","volume":"117","author":"Koppel","year":"2018","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0350","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1043-2760(00)00370-2","article-title":"Is there an astrocyte\u2013neuron ketone body shuttle?","volume":"12","author":"Guzm\u00e1n","year":"2001","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0355","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/neup.12639","article-title":"Metabolic compartmentalization between astroglia and neurons in physiological and pathophysiological conditions of the neurovascular unit","volume":"40","author":"Takahashi","year":"2020","journal-title":"Neuropathology"},{"key":"10.1016\/j.maturitas.2022.06.001_bb0360","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3389\/fnmol.2016.00053","article-title":"Can ketones help rescue brain fuel supply in later life? Implications for cognitive health during aging and the treatment of Alzheimer's disease","volume":"9","author":"Cunnane","year":"2016","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0365","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.pneurobio.2016.10.001","article-title":"Insulin resistance and Parkinson's disease: a new target for disease modification?","volume":"145\u2013146","author":"Athauda","year":"2016","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0370","doi-asserted-by":"crossref","DOI":"10.3390\/cells9030740","article-title":"Insulin resistance promotes Parkinson's disease through aberrant expression of \u03b1-synuclein, mitochondrial dysfunction, and deregulation of the polo-like kinase 2 signaling","volume":"9","author":"Hong","year":"2020","journal-title":"Cells"},{"key":"10.1016\/j.maturitas.2022.06.001_bb0375","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.expneurol.2011.06.005","article-title":"Insulin resistance impairs nigrostriatal dopamine function","volume":"231","author":"Morris","year":"2011","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0380","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0304-3940(96)12357-0","article-title":"Insulin receptor mRNA in the substantia nigra in Parkinson's disease","volume":"204","author":"Takahashi","year":"1996","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.135754","article-title":"Therapies modulating insulin resistance in Parkinson's disease: a cross talk","volume":"749","author":"Sharma","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0390","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.biocel.2015.03.006","article-title":"Alpha-synuclein overexpression negatively regulates insulin receptor substrate 1 by activating mTORC1\/S6K1 signaling","volume":"64","author":"Gao","year":"2015","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0395","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3233\/JPD-161055","article-title":"A consensus set of outcomes for Parkinson's disease from the international consortium for health outcomes measurement","volume":"7","author":"De Roos","year":"2017","journal-title":"J. Parkinsons. Dis."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0400","article-title":"Limitations of animal models of Parkinson's disease","volume":"2011","author":"Potashkin","year":"2011","journal-title":"Parkinsons Dis."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0405","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.3233\/JPD-202200","article-title":"Animal models of Parkinson's disease: are they useful or not?","volume":"10","author":"Barker","year":"2020","journal-title":"J. Parkinsons. Dis."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0410","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1016\/j.parkreldis.2008.04.004","article-title":"Strengths and limitations of genetic mouse models of Parkinson's disease","volume":"14","author":"Chesselet","year":"2008","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0415","doi-asserted-by":"crossref","first-page":"155","DOI":"10.3389\/fnana.2014.00155","article-title":"Parkinson's disease: animal models and dopaminergic cell vulnerability","volume":"8","author":"Blesa","year":"2014","journal-title":"Front. Neuroanat."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0420","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3389\/fnins.2015.00503","article-title":"Evaluation of models of Parkinson's disease","volume":"9","author":"Jagmag","year":"2016","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0425","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1002\/mds.28145","article-title":"A prospective validation of the updated movement disorders society research criteria for prodromal Parkinson's disease","volume":"35","author":"Giagkou","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0430","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1002\/mds.27792","article-title":"Motor function and the probability of prodromal Parkinson's disease in older adults","volume":"34","author":"Maraki","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.maturitas.2022.06.001_bb0435","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/mds.27489","article-title":"Mediterranean diet adherence is related to reduced probability of prodromal Parkinson's disease","volume":"34","author":"Maraki","year":"2019","journal-title":"Mov. Disord."}],"container-title":["Maturitas"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512222001190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378512222001190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T09:20:46Z","timestamp":1759915246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378512222001190"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":87,"alternative-id":["S0378512222001190"],"URL":"https:\/\/doi.org\/10.1016\/j.maturitas.2022.06.001","relation":{},"ISSN":["0378-5122"],"issn-type":[{"value":"0378-5122","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ketogenic therapy for Parkinson's disease: A systematic review and synthesis without meta-analysis of animal and human trials","name":"articletitle","label":"Article Title"},{"value":"Maturitas","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.maturitas.2022.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}